Chlorella ingestion in borderline diabetics: a double blind, placebo-controlled study and open study - Chlorella ingestion in borderline diabetics

Sun Chlorella Corp.0 个研究点目标入组 60 人开始时间: 2013年8月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)BMI>30 2)Patient of the Diabetes or hypertension or hyperlipidemia. systolic blood pressure > 160 mmHg diastolic blood > 100 mmHg HbA1c > 7.4% LDL-Cholesterol > 190 mg/dL 3)These prescreened medicine. 4)These having Food for Specified Health Uses (FOSHU) and/or health food. 5)These having a history of serious diseases in metabolic and/or endocrine system. 6)Those that have extremely disheveled lifestyle and/or dietary habits. 7)Heavy alcohol drinker. 8)Those that are considered to be ineligible to participate to this test due to their abnormality at the screening test. 9)Diabetes or hypertension or hyperlipidemia patient who is NOT accompanied by obesity, but whose disease is attributed etiologically to hereditary factor or other non-obesity factors. 10)Those that are judged not applicable to this study by physicians. 11)The subject who takes warfarin. 12)Those participating in another trial or other investigational.

发起方

Sun Chlorella Corp.